TR199800244T2 - Griseofulvinin, kanserlerin ilerlemesini önlemede kullanimi. - Google Patents

Griseofulvinin, kanserlerin ilerlemesini önlemede kullanimi.

Info

Publication number
TR199800244T2
TR199800244T2 TR1998/00244T TR9800244T TR199800244T2 TR 199800244 T2 TR199800244 T2 TR 199800244T2 TR 1998/00244 T TR1998/00244 T TR 1998/00244T TR 9800244 T TR9800244 T TR 9800244T TR 199800244 T2 TR199800244 T2 TR 199800244T2
Authority
TR
Turkey
Prior art keywords
griseofulvin
cancers
progression
preventing
potentiators
Prior art date
Application number
TR1998/00244T
Other languages
English (en)
Inventor
Berger Camden James
Original Assignee
The Procter & Gamble Company
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by The Procter & Gamble Company filed Critical The Procter & Gamble Company
Publication of TR199800244T2 publication Critical patent/TR199800244T2/tr

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A61K31/343Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

Memelilerde görülen kanserleri tedavi etmeye mahsus ve griseofulvini içeren bir farmasötik bilesim açiklanmaktadir. Griseofulvin ile beraber, etki güçlendirici maddeler olarak bir kemoterapötik madde kullanilabilir. Sözü edilen griseofulvin, ya tek basina veya baska viral maddelerle veya bir etki-güçlendirici maddeyle birlikte, viral enfeksiyonlarin tedavisinde de kullanilabilir.
TR1998/00244T 1995-08-03 1996-07-30 Griseofulvinin, kanserlerin ilerlemesini önlemede kullanimi. TR199800244T2 (tr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US183995P 1995-08-03 1995-08-03
US67418196A 1996-07-16 1996-07-16

Publications (1)

Publication Number Publication Date
TR199800244T2 true TR199800244T2 (tr) 1998-09-21

Family

ID=26669547

Family Applications (1)

Application Number Title Priority Date Filing Date
TR1998/00244T TR199800244T2 (tr) 1995-08-03 1996-07-30 Griseofulvinin, kanserlerin ilerlemesini önlemede kullanimi.

Country Status (16)

Country Link
EP (1) EP0841914A2 (tr)
JP (1) JPH11511136A (tr)
KR (1) KR19990036137A (tr)
AR (1) AR003176A1 (tr)
AU (1) AU713031B2 (tr)
BR (1) BR9609920A (tr)
CA (1) CA2228503A1 (tr)
CZ (1) CZ30598A3 (tr)
HU (1) HUP9903506A3 (tr)
IL (1) IL123094A0 (tr)
MX (1) MX9800945A (tr)
NO (1) NO980420L (tr)
PL (1) PL324905A1 (tr)
SK (1) SK14298A3 (tr)
TR (1) TR199800244T2 (tr)
WO (1) WO1997005870A2 (tr)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6479526B1 (en) 1995-04-12 2002-11-12 The Procter & Gamble Company Pharmaceutical composition for inhibiting the growth of viruses and cancers
US6262093B1 (en) 1995-04-12 2001-07-17 The Proctor & Gamble Company Methods of treating cancer with benzimidazoles
US6177460B1 (en) 1995-04-12 2001-01-23 The Procter & Gamble Company Method of treatment for cancer or viral infections
US6265427B1 (en) 1995-06-07 2001-07-24 The Proctor & Gamble Company Pharmaceutical composition for the method of treating leukemia
US5770616A (en) 1995-06-07 1998-06-23 The Procter & Gamble Company Pharmaceutical composition for inhibiting the growth of cancers
US6686391B2 (en) 1995-08-04 2004-02-03 University Of Arizona Foundation N-chlorophenylcarbamate and N-chlorophenylthiocarbamate compositions
US5900429A (en) 1997-01-28 1999-05-04 The Procter & Gamble Company Method for inhibiting the growth of cancers
US6506783B1 (en) 1997-05-16 2003-01-14 The Procter & Gamble Company Cancer treatments and pharmaceutical compositions therefor
US6245789B1 (en) 1998-05-19 2001-06-12 The Procter & Gamble Company HIV and viral treatment
CA2337690C (en) * 1998-07-27 2013-10-01 Texas Pharmaceuticals, Inc. Chemically induced intracellular hyperthermia
DK2055313T3 (en) 1998-11-09 2015-07-27 Biogen Inc Treatment of Hematologic Malignancies Related to Circulating Tumor Cells Using Chimeric Anti-CD20 Antibody
US6423734B1 (en) 1999-08-13 2002-07-23 The Procter & Gamble Company Method of preventing cancer
US6407105B1 (en) 2000-09-26 2002-06-18 The Procter & Gamble Company Compounds and methods for use thereof in the treatment of cancer or viral infections
US6608096B1 (en) 2000-09-26 2003-08-19 University Of Arizona Foundation Compounds and methods for use thereof in the treatment of cancer or viral infections
US6380232B1 (en) 2000-09-26 2002-04-30 The Procter & Gamble Company Benzimidazole urea derivatives, and pharmaceutical compositions and unit dosages thereof
US6462062B1 (en) 2000-09-26 2002-10-08 The Procter & Gamble Company Compounds and methods for use thereof in the treatment of cancer or viral infections
DK1407784T3 (da) * 2001-06-25 2011-02-28 Ajinomoto Kk Antitumormidler
EP2008652A1 (en) * 2007-06-28 2008-12-31 Deutsches Krebsforschungszentrum Stiftung des öffentlichen Rechts Griseofulvin analogues for the treatment of cancer by inhibition of centrosomal clustering
EP2204367A1 (en) * 2008-12-22 2010-07-07 Deutsches Krebsforschungszentrum Stiftung des öffentlichen Rechts Griseofulvin analogues for the treatment of cancer by inhibition of centrosomal clustering

Also Published As

Publication number Publication date
NO980420D0 (no) 1998-01-30
WO1997005870A2 (en) 1997-02-20
HUP9903506A2 (hu) 2000-06-28
HUP9903506A3 (en) 2000-07-28
EP0841914A2 (en) 1998-05-20
SK14298A3 (en) 1998-09-09
BR9609920A (pt) 1999-07-06
KR19990036137A (ko) 1999-05-25
AR003176A1 (es) 1998-07-08
CA2228503A1 (en) 1997-02-20
JPH11511136A (ja) 1999-09-28
MX9800945A (es) 1998-04-30
NO980420L (no) 1998-04-03
IL123094A0 (en) 1998-09-24
AU713031B2 (en) 1999-11-18
AU6683496A (en) 1997-03-05
WO1997005870A3 (en) 1997-04-17
PL324905A1 (en) 1998-06-22
CZ30598A3 (cs) 1998-06-17

Similar Documents

Publication Publication Date Title
TR199800244T2 (tr) Griseofulvinin, kanserlerin ilerlemesini önlemede kullanimi.
GT199800126A (es) Terapia de combinacion.
YU47993B (sh) Derivati 2,4-diaminohinazolina
DK0981607T3 (da) Modificeret arginin-deiminase
TR200201484T2 (tr) Çeşitli hastalıkların koruyucu ve iyileştirici tedavisi için bakteriyel fajlar ile ilişkili lisleme enzimlerinin kullanımı
HK1026691A1 (en) Substituted benzimidazoles and their use for treating retroviral infection
NZ241627A (en) Quinazoline derivatives and anti-tumour compositions
FI964681A0 (fi) Ihmisperäiset Lactobacillus-kannat, niitä sisältävät valmisteet ja niiden käytöt
TR199701147T1 (tr) Kanserlerin gelismesini önlemeye mahsus, benzimidazol içeren bir farmasötik bilesim.
TR199701148T1 (tr) Virüslerin ve kanserlerin gelismesini önlemeye mahsus, N-fosfonoglisin türevlerini içeren bir farmasötik bilesim.
YU194691A (sh) Benzodiazepinoni
ATE201591T1 (de) Vorbeugung und behandlung von topischen viralen infektionen mit perfluoropolyäthern oder deren zusammensetzungen
PL322732A1 (en) Pharmaceutic agent containing n-chlorophenyl carbaminates and n-chlorophenyl thiocarbaminates for inhibiting development of viruses and carcinoma
MX9800944A (es) Uso de derivados de 1h-1,2,4-triazol para inhibir el crecimiento de canceres.
TR199802351T2 (tr) Topikal kullanim için bir veya birden fazla lokal anestezik ve anti-vajinit maddeler ihtiva eden anti-vajinit bilesimi.
TR199900505T2 (tr)
TR200101493T2 (tr) Eletriptan hidrobromid monohidrat
FI934565A0 (fi) Pyrimidinderivat foer att oeka antitumoeraktiviteten
ATE199641T1 (de) Terpenderivate (sarcodictyine) als antikrebsmittel
ATE317263T1 (de) Diphosphonat derivate von therapeutisch wirksamen stoffen
TR200001715T2 (tr) Potasyum kanalı açıcıları.
MY110998A (en) Antibiotic combination
LV11593A (lv) Dimetikona pielietojums aizcietejumu arstesana
MX9707808A (es) Una composicion farmaceutica que contiene n-clorofenilcarbamatos y n-clorofiniltiocarbamatos para inhibir el crecimiento de virus y canceres.
ATE200026T1 (de) Behandlung von laminitis